Skip to main content
. Author manuscript; available in PMC: 2014 Nov 3.
Published in final edited form as: Leukemia. 2009 Sep 10;23(12):2275–2280. doi: 10.1038/leu.2009.181

Table 3. History of AHD/MDS and Chemotherapy/Radiotherapy in Patients with AML-M6.

Disease Number (%)
AHD/MDS
MDS 45 (41.6)
Cytopenias 5 (4.6)
Polycythemia Vera 1 (0.9)
Essential Thrombocythemia 1 (0.9)
Polycythemia Vera + MDS 1 (0.9)
Chronic Lymphocytic Leukemia + MDS 1(0.9)
Previous Chemotherapy and/or Radiaton Therapy
Breast Cancer 7 (6.5)
Non-Hodgkin's Lymphoma 4 (3.7)
Multiple Myeloma 3 (2.7)
Hodgkin's Lymphoma 2 (1.8)
Prostate Cancer 2 (1.8)
Head and Neck Cancer 2 (1.8)
Acute Lymphoblastic Leukemia 2 (1.8)
Chronic Lymphocytic Leukemia 1 (0.9)
Lung Cancer 1 (0.9)
Osteosarcoma 1 (0.9)
Ovarian Cancer 1 (0.9)
Allogeneic SCT for MDS 1 (0.9)